Results of studies conducted 10-20 years ago show the prominence of commercial information sources in the adoption process of new drugs. Over the past decade, there has been a growing emphasis on practicing evidence-based medicine in drug prescribing. This raises the question whether professional information sources currently counterbalance the influence of commercial information sources in the adoption process. The aim of this study was to identify determinants influencing the adoption of a new drug class, the angiotensin II receptor blockers (ARBs), by general practitioners (CPs) in The Netherlands. A retrospective study was conducted to assess prevalent ARB prescribing for hypertensive patients,using the Integrated Primary Care Informati...
OBJECTIVE: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective Concerns exist about heavily prescribing of new drugs when the evidence on hard outcomes i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Objective: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Citation for published version (APA): Greving, JP., Denig, P., van der Veen, WJ., Beltman, FW., Stur...
OBJECTIVE: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective Concerns exist about heavily prescribing of new drugs when the evidence on hard outcomes i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Results of studies conducted 10-20 years ago show the prominence of commercial information sources i...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Hart- en vaatziekten behoren tot de belangrijkste doodsoorzaken in de westerse wereld. De behandelin...
Objective: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Citation for published version (APA): Greving, JP., Denig, P., van der Veen, WJ., Beltman, FW., Stur...
OBJECTIVE: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective: To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial an...
Objective Concerns exist about heavily prescribing of new drugs when the evidence on hard outcomes i...